HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Investigations of seborrheic dermatitis. Part II. Influence of itraconazole on the clinical condition and the level of selected cytokines in seborrheic dermatitis.

AbstractINTRODUCTION:
The pathogenesis of seborrheic dermatitis has not been fully elucidated. A number of anascogenic yeasts of Malassezia spp. appear to be involved in the intensity of the symptoms. The purpose of the study is to evaluate the levels of selected inflammatory cytokines, IL-2, IL-4, IFN-γ and TNF-α, in the serum after treatment with itraconazole.
MATERIAL/METHODS:
Sixty-six subjects were enrolled in the study. The control group consisted of 30 participants (23 females and 7 males) without any clinical disorders, aged 24-65 (37.41±6.08 years). Thirty-six patients with seborrheic dermatitis (16 females and 20 males), aged 19-76 (38.61±13.77), constituted the study group. The measurement of IL-2, IL-4, IFN-γ and TNF-α levels was performed by ELISA using a Human High Sensitivity kit (Diaclone, France).
RESULTS:
After six-week treatment with itraconazole administered daily at a dose of 200 mg using pulse therapy, there was remission of the disease or at least substantial clinical improvement in the patients with seborrheic dermatitis. The levels of IL-2 and IFN-γ cytokines in the study group were higher than in the control group. After the treatment the level of IFN-γ secretion in the male patients with seborrheic dermatitis significantly increased. The levels of the other studied cytokines did not significantly differ.
CONCLUSIONS:
The treatment with itraconazole had a beneficial effect on the clinical condition of the skin of the patients. IFN-γ is a cytokine whose secretion might affect the condition of the skin in seborrheic dermatitis.
AuthorsEwa Trznadel-Grodzka, Marcin Błaszkowski, Helena Rotsztejn
JournalPostepy higieny i medycyny doswiadczalnej (Online) (Postepy Hig Med Dosw (Online)) Vol. 66 Pg. 848-54 (Nov 14 2012) ISSN: 1732-2693 [Electronic] Poland
PMID23175341 (Publication Type: Controlled Clinical Trial, Journal Article)
Chemical References
  • Antifungal Agents
  • Cytokines
  • Interleukin-2
  • Tumor Necrosis Factor-alpha
  • Interleukin-4
  • Itraconazole
  • Interferon-gamma
Topics
  • Adult
  • Aged
  • Antifungal Agents (administration & dosage)
  • Cytokines (metabolism)
  • Dermatitis, Seborrheic (drug therapy, metabolism, microbiology)
  • Drug Administration Schedule
  • Female
  • Humans
  • Interferon-gamma (metabolism)
  • Interleukin-2 (metabolism)
  • Interleukin-4 (metabolism)
  • Itraconazole (administration & dosage)
  • Malassezia (drug effects)
  • Male
  • Middle Aged
  • Pulse Therapy, Drug
  • Tumor Necrosis Factor-alpha (metabolism)
  • Young Adult

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: